Cornelia G van Helden-Meeuwsen

Author

Also Known As

C G Van Helden-Meeuwsen, C G van Helden-Meeuwsen, C. G. VAN HELDEN‐MEEUWSEN, C. G. Van Helden-Meeuwsen, C.G. Van Helden-Meeuwsen, C.G. van Helden-Meeuwsen, Cornelia G Van Helden-Meeuwsen, Cornelia G van Helden-Meeuwsen, Cornelia G. van Helden-Meeuwsen, Cornelia G. van Helden‐Meeuwsen

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam University Medical Center Utrecht Utrecht University Rotterdam University of Applied Sciences

About

Cornelia G van Helden-Meeuwsen is an author at Erasmus MC specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	589
2	Allergy	4	4	285
3	Health Sciences	1	1	61
4	Allergy Medicine	1	1	28
5	Biochemistry	1	1	61

Cornelia G van Helden-Meeuwsen

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression Zana Brkić, Naomi I. Maria, Cornelia G van Helden-Meeuwsen, Annals of the Rheumatic Diseases	2012	295
Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids Gertrude M. Möller, S. E. OVERBBEK, Cornelia G van Helden-Meeuwsen, Clinical & Experimental Allergy	1996	185
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis Zana Brkić, Lenny van Bon, Marta Cossu, Annals of the Rheumatic Diseases	2015	170
Systemic increase in type I interferon activity in Sjögren's syndrome: A putative role for plasmacytoid dendritic cells Manon E. Wildenberg, Cornelia G van Helden-Meeuwsen, J.P. van de Merwe, European Journal of Immunology Systemic IncreaseIfn BioactivityImmunologyImmune RegulationPathology	2008	161
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome Naomi I. Maria, Zana Brkić, Matti Waris, Annals of the Rheumatic Diseases	2013	123
Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity Iris L. A. Bodewes, Shereen Al-Ali, Cornelia G van Helden-Meeuwsen, Lara D. Veeken	2018	111
Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype Hui Wan, Marjan A. Versnel, Lonneke Leijten, Journal of Leukocyte Biology	2008	87
Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome Naomi I. Maria, Eline C. Steenwijk, Arne IJpma, Annals of the Rheumatic Diseases	2016	78
Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors? M. J. Wahadat, Iris L. A. Bodewes, Naomi I. Maria, Arthritis Research & Therapy	2018	74
Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial Iris L. A. Bodewes, Jacques‐Eric Gottenberg, Cornelia G van Helden-Meeuwsen, Lara D. Veeken	2019	72

Page 1